TY - JOUR
T1 - Epilepsy in the setting of full trisomy 18: A multicenter study on 18 affected children with and without structural brain abnormalities
AU - Matricardi, Sara
AU - Spalice, Alberto
AU - Salpietro, Vincenzo
AU - Di Rosa, Gabriella
AU - Balistreri, Maria Cristina
AU - Grosso, Salvatore
AU - Parisi, Pasquale
AU - Elia, Maurizio
AU - Striano, Pasquale
AU - Accorsi, Patrizia
AU - Cusmai, Raffaella
AU - Specchio, Nicola
AU - Coppola, Giangennaro
AU - Savasta, Salvatore
AU - Carotenuto, Marco
AU - Tozzi, Elisabetta
AU - Ferrara, Pietro
AU - Ruggieri, Martino
AU - Verrotti, Alberto
PY - 2016
Y1 - 2016
N2 - This paper reports on the clinical aspects, electroencephalographic (EEG) features, and neuroimaging findings in children with full trisomy 18 and associated epilepsy, and compares the evolution and outcome of their neurological phenotype. We retrospectively studied 18 patients (10 males and 8 females; aged 14 months to 9 years) with full trisomy 18 and epilepsy. All patients underwent comprehensive assessment including neuroimaging studies of the brain. We divided patients into two groups according to neuroimaging findings: (Group 1) 10 patients harboring structural brain malformations, and (Group 2) 8 patients with normal brain images. Group 1 had a significantly earlier age at seizure onset (2 months) compared to Group 2 (21 months). The seizure semiology was more severe in Group 1, who presented multiple seizure types, need for polytherapy (80% of patients), multifocal EEG abnormalities and poorer outcome (drug resistant epilepsy in 90% of patients) than Group 2 who presented a single seizure type, generalized or focal, and non-specific EEG pattern; these patients were successfully treated with monotherapy with good outcome. Imaging revealed a wide and complex spectrum of structural brain abnormalities including anomalies of the commissures, cerebellar malformations, cortical abnormalities, and various degrees of cortical atrophy. Epilepsy in full trisomy 18 may develop during the first months of life and can be associated with structural brain malformations. Patients with brain malformations can show multiple seizure types and can frequently be resistant to therapy with antiepileptic drugs.
AB - This paper reports on the clinical aspects, electroencephalographic (EEG) features, and neuroimaging findings in children with full trisomy 18 and associated epilepsy, and compares the evolution and outcome of their neurological phenotype. We retrospectively studied 18 patients (10 males and 8 females; aged 14 months to 9 years) with full trisomy 18 and epilepsy. All patients underwent comprehensive assessment including neuroimaging studies of the brain. We divided patients into two groups according to neuroimaging findings: (Group 1) 10 patients harboring structural brain malformations, and (Group 2) 8 patients with normal brain images. Group 1 had a significantly earlier age at seizure onset (2 months) compared to Group 2 (21 months). The seizure semiology was more severe in Group 1, who presented multiple seizure types, need for polytherapy (80% of patients), multifocal EEG abnormalities and poorer outcome (drug resistant epilepsy in 90% of patients) than Group 2 who presented a single seizure type, generalized or focal, and non-specific EEG pattern; these patients were successfully treated with monotherapy with good outcome. Imaging revealed a wide and complex spectrum of structural brain abnormalities including anomalies of the commissures, cerebellar malformations, cortical abnormalities, and various degrees of cortical atrophy. Epilepsy in full trisomy 18 may develop during the first months of life and can be associated with structural brain malformations. Patients with brain malformations can show multiple seizure types and can frequently be resistant to therapy with antiepileptic drugs.
KW - Edwards syndrome
KW - epilepsy
KW - outcome
KW - structural brain malformations
KW - trisomy 18
KW - Edwards syndrome
KW - epilepsy
KW - outcome
KW - structural brain malformations
KW - trisomy 18
UR - http://hdl.handle.net/10807/90972
U2 - 10.1002/ajmg.c.31513
DO - 10.1002/ajmg.c.31513
M3 - Article
SN - 1552-4868
VL - 172
SP - 288
EP - 295
JO - AMERICAN JOURNAL OF MEDICAL GENETICS. PART C, SEMINARS IN MEDICAL GENETICS
JF - AMERICAN JOURNAL OF MEDICAL GENETICS. PART C, SEMINARS IN MEDICAL GENETICS
ER -